Floatz logo

714 assets in Colorectal Cancer

Therapeutic assets addressing Colorectal Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fermented Wheat Germ Extract
Colorectal Cancer
University of California, DavisP1CC (43)
Fianlimab
Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2CC (43)
Fluzoparib
Colorectal Cancer
Huazhong University of Science and TechnologyP2CC (43)
Fulzerasib
Colorectal Cancer
Zhejiang UniversityP2CC (43)
gen1042
Colorectal Cancer
GenmabP1/2CC (43)
gi-102
Colorectal Cancer
GI Innovation, Inc.P1/2CC (43)
hc-7366
Colorectal Cancer
HiberCell, Inc.P1CC (43)
iam1363
Colorectal Cancer
Iambic Therapeutics, IncP1CC (43)
ibi363
Colorectal Cancer
Innovent Biologics (Suzhou) Co. Ltd.P2CC (43)
Ibuprofen
Colorectal Cancer
Cairo UniversityP2CC (43)
Immunoglobulin G1, Anti-(Human Cytotoxic T-Lymphocyte-Associated Antigen 4) (Human-Mus Musculus Monoclonal M3 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal M3 .Kappa.-Chain, Dimer
Colorectal Cancer
Merck Sharp & Dohme LLCP2CC (43)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P2CC (43)
Immunoglobulin Half-Ig G1-Kappa/Scfv-H-Ch2-Ch3, Anti-(Homo Sapiens Ctla4 (Cytotoxic T-Lymphocyte-Associated Protein 4, Cd152)) And Anti-(Homo Sapienspdcd1 (Programmed Cell Death 1, Pd-1, Pd1, Cd279)), Monoclonal Antibody, Bispecific
Colorectal Cancer
M.D. Anderson Cancer CenterP2CC (43)
Imu-201 (Pd1-Vaxx)
Colorectal Cancer
University of SouthamptonP2CC (43)
Kras-Specific Autologous Tcr-T Cell
Colorectal Cancer
Corregene Biotechnology Co., LtdP1CC (43)
Lenalidomide
Colorectal Cancer
Sun Yat-sen UniversityP2CC (43)
Leronlimab
Colorectal Cancer
CytoDyn, Inc.P2CC (43)
Lobaplatin
Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP2CC (43)
Losartan
Colorectal Cancer
Ain Shams UniversityP2CC (43)
LY3143921
Colorectal Cancer
Cancer Research UKP1CC (43)
Magicell-Nk Contains Nk Cells Suspended In Normal Saline
Colorectal Cancer
Medigen Biotechnology CorporationP1CC (43)
Medium Dose Msh2-/- Tumor Cell Vaccine
Colorectal Cancer
West China HospitalP1CC (43)
Mirabegron
Colorectal Cancer
Zhejiang Provincial People's HospitalP2CC (43)
mk-4830
Colorectal Cancer
Merck Sharp & Dohme LLCP2CC (43)
Mrtx0902
Colorectal Cancer
Mirati Therapeutics Inc.P1CC (43)
Mrtx1133
Colorectal Cancer
Mirati Therapeutics Inc.P1CC (43)
Naproxen
Colorectal Cancer
M.D. Anderson Cancer CenterP2CC (43)
Navicixizumab
Colorectal Cancer
OncXerna Theraputics, Inc.P2CC (43)
Neoantigen Dendritic Cell Vaccine
Colorectal Cancer
National Cancer Centre, SingaporeP2CC (43)
Nocardia Rubra Cell Wall Skeleton
Colorectal Cancer
Sun JingP2CC (43)
Ono-7913
Colorectal Cancer
Ono Pharmaceutical Co., Ltd.P1CC (43)
Pd-L1 T-Hank
Colorectal Cancer
ImmunityBio, Inc.P2CC (43)
Qbeco
Colorectal Cancer
Sunnybrook Health Sciences CentreP2CC (43)
Recombinant Mutant Human Tumor Necrosis Factor
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CC (43)
Rilvegostomig
Colorectal Cancer
AstraZenecaP2CC (43)
Romiplostim
Colorectal Cancer
Peking University People's HospitalP2CC (43)
Shr-3821
Colorectal Cancer
Meng QiuP2CC (43)
Si-B001
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P2CC (43)
Si-B003
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P2CC (43)
S,S-Adenosylmethionine
Colorectal Cancer
Jun Gong, MDP1CC (43)
th9619
Colorectal Cancer
One-carbon Therapeutics ABP1/2CC (43)
Tirzepatide
Colorectal Cancer
Massachusetts General HospitalP1CC (43)
Tovecimig
Colorectal Cancer
Washington University School of MedicineP2CC (43)
Tretinoin
Colorectal Cancer
Peking University People's HospitalP2CC (43)
tt-10
Colorectal Cancer
Portage BiotechP1/2CC (43)
vet3-tgi
Colorectal Cancer
KaliVir ImmunotherapeuticsP1CC (43)
Vibostolimab
Colorectal Cancer
Merck Sharp & Dohme LLCP2CC (43)
Vmd-102
Colorectal Cancer
VM Discovery, Inc.P1/2CC (43)
Volrustomig
Colorectal Cancer
AstraZenecaP2CC (43)
Xmt-2056
Colorectal Cancer
Day One Biopharmaceuticals, Inc.P1CC (43)
Showing 351 to 400 of 714 assets
PreviousPage 8 of 15Next